World of Bacteria header image

Klebsiella pneumoniae

Klebsiella pneumoniae is an encapsulated, non-motile, lactose-fermenting Gram-negative rod that colonizes the human gastrointestinal tract and is an important cause of urinary tract infection, pneumonia, bloodstream infection, and healthcare-associated disease.

Basic Characteristics

Taxonomy

  • Domain: Bacteria
  • Phylum: Pseudomonadota (Proteobacteria)
  • Class: Gammaproteobacteria
  • Order: Enterobacterales
  • Family: Enterobacteriaceae
  • Genus: Klebsiella
  • Species: Klebsiella pneumoniae

Microscopy & Gram Stain

  • Gram-negative, relatively short and plump rods
  • Cells occur singly, in pairs, and occasionally in short chains
  • Capsular material may appear as a pale, unstained halo around the cells

Oxygen Relationship

  • Facultatively anaerobic

Rapid Identification Tests

  • Oxidase: negative
  • Catalase: positive
  • Motility: negative
  • Lactose fermentation: positive
  • Urease: usually positive
  • Indole: usually negative for typical K. pneumoniae isolates
  • Citrate: positive
  • Hydrogen sulphide: negative

Ecology and Clinical Relevance

Natural Habitat

  • Human gastrointestinal tract
  • May colonize the oropharynx and other mucosal sites
  • Soil, water, plants, sewage, and other environmental reservoirs
  • Healthcare environments and colonized patients may serve as sources of transmission

Common Clinical Specimens

  • Urine and catheter urine
  • Blood cultures
  • Sputum, tracheal aspirates, and other respiratory specimens
  • Wound and surgical-site specimens
  • Abscess material, including liver abscesses
  • Cerebrospinal fluid and other normally sterile specimens

Clinical Significance

  • Common cause of urinary tract infection, particularly in hospitalized or catheterized patients
  • Important cause of healthcare-associated pneumonia and bloodstream infection
  • May cause wound infection, intra-abdominal infection, neonatal disease, and meningitis
  • Hypervirulent lineages may cause community-onset invasive disease, including liver abscess with metastatic spread
  • Carbapenem-resistant and other multidrug-resistant lineages are major infection-control and public-health concerns

Differential Considerations

  • Other members of the Klebsiella pneumoniae species complex, especially K. variicola and K. quasipneumoniae
  • Klebsiella oxytoca, which is usually indole positive
  • Escherichia coli, which is motile and usually less prominently mucoid
  • Enterobacter, Raoultella, and other lactose-fermenting Enterobacterales

Diagnostic and Clinical Notes

Klebsiella pneumoniae is a common intestinal colonizer and an important opportunistic pathogen in both community and healthcare settings. It is particularly prominent in urinary tract infections, pneumonia, bloodstream infections, and infections involving critically ill or instrumented patients.

Abundant capsular and extracellular polysaccharide production gives many isolates their characteristic smooth, glistening, or mucoid appearance. The degree of mucoidy varies substantially and may be affected by strain background and culture conditions.

A strongly mucoid colony or a positive string test should not be treated as proof of hypervirulence. Hypervirulent and classical lineages overlap phenotypically, and reliable characterization requires clinical correlation and detection of appropriate molecular markers.

The species belongs to a closely related complex that includes K. variicola and K. quasipneumoniae. Routine systems identify most clinical isolates correctly, but difficult or epidemiologically important isolates may require updated MALDI-TOF databases, targeted molecular tests, or whole-genome sequencing.

In urine culture, colony quantity, specimen quality, pyuria, symptoms, catheter status, and accompanying organisms remain essential for distinguishing infection from colonization or contamination. Colony texture does not predict susceptibility: ordinary-looking isolates may carry extended-spectrum beta-lactamases or carbapenemases.

Laboratory Identification

Colony Morphology

On blood agar after 18–24 hours at 35–37 °C, Klebsiella pneumoniae usually forms medium-sized to large, grey-white, smooth, convex, glistening colonies with entire margins. Capsule and extracellular polysaccharide production may create a distinctly mucoid consistency, although the intensity of this phenotype varies between isolates.

Microscopy

Gram staining shows relatively short, plump Gram-negative rods occurring singly, in pairs, or occasionally in short chains. Capsular material may be seen indirectly as a pale halo, but ordinary Gram staining is not a definitive capsule demonstration method.

Key Identification Clues

  • Gram-negative, encapsulated rod
  • Facultatively anaerobic
  • Oxidase negative and catalase positive
  • Non-motile
  • Lactose fermenting
  • Usually urease and citrate positive
  • Usually indole negative for typical K. pneumoniae
  • Smooth, glistening, and sometimes markedly mucoid colonies

Modern Identification Methods

Routine identification is commonly performed by MALDI-TOF mass spectrometry or automated biochemical systems. Updated reference databases improve recognition within the K. pneumoniae species complex. Molecular assays are used to detect important resistance genes and selected hypervirulence-associated markers, while whole-genome sequencing provides the highest resolution for species-complex assignment, outbreak investigation, resistance analysis, and lineage characterization.

Antibiotic Characteristics

Klebsiella pneumoniae is intrinsically resistant to ampicillin and related narrow-spectrum aminopenicillins because of a chromosomally encoded beta-lactamase.

Clinical isolates may acquire extended-spectrum beta-lactamases, plasmid-mediated AmpC enzymes, aminoglycoside and fluoroquinolone resistance, and carbapenemases such as KPC, NDM, OXA-48-like, VIM, or IMP enzymes.

Carbapenem-resistant K. pneumoniae belongs to the most important multidrug-resistant Gram-negative threats in healthcare. Convergence of carbapenem resistance with hypervirulent lineages is of particular concern because it combines invasive potential with limited treatment options.

Resistance to last-line agents may also occur through additional acquired genes or chromosomal alterations, and the expected activity of an antimicrobial agent cannot be inferred from colony morphology or source alone.

Note: Treatment and infection-control decisions should be guided by the infection site, patient factors, susceptibility testing, and, where relevant, laboratory detection of extended-spectrum beta-lactamases or carbapenemases.

External Resources

For broader information about Klebsiella pneumoniae, its clinical importance, antimicrobial resistance, and current taxonomy, see: